Nuclear factor of activated T-cells, cytoplasmic 2 (NFAT1) (NFAT1)

Nuclear factor of activated T-cells, cytoplasmic 2 (NFAT1) is a key transcription factor that mediates the adaptive immune response by regulating the expression of cytokines such as interleukin-2 (IL-2) and interleukin-4 (IL-4) (UniProt, PubMed). It is primarily controlled by the calcium-calcineurin signaling pathway, where the phosphatase calcineurin dephosphorylates NFAT1 in response to elevated intracellular calcium, allowing its translocation from the cytoplasm to the nucleus (PubMed, NIH). Beyond its role in T-cell activation, NFAT1 is involved in diverse physiological processes including cell cycle regulation, apoptosis, angiogenesis, and the maintenance of articular cartilage (PubMed, PMC). Dysregulation of NFAT1 signaling is strongly linked to the pathogenesis of autoimmune diseases, chronic inflammation, and various malignancies, including breast and colon cancers, where it promotes tumor invasion and metastasis (PubMed, PMC). Pharmacological modulation of NFAT1 is a cornerstone of immunosuppressive therapy, primarily through the use of calcineurin inhibitors like cyclosporine and tacrolimus (PubMed, NIH). However, therapeutic challenges include the risk of systemic immunosuppression, nephrotoxicity, and potential long-term risks of malignancy associated with chronic inhibition (PubMed, Blood).

Other names

NFATC2NFATpNFATc2Nuclear factor of activated T-cells 1

Inhibition of calcineurin-mediated dephosphorylation, preventing nuclear translocation and subsequent DNA binding of NFAT1 to target gene promoters.